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Summary 
X-linked agammaglobulinemia, a B cell immunodeficiency, is caused by mutations in the Bruton's 
tyrosine kinase (Btk)  gene. The absence of a functional Btk protein leads to a failure of B cell 
differentiation and antibody production. B cell receptor stimulation leads to the phosphorylation 
of the Btk protein and it is, therefore, likely that Btk is involved in B cell receptor signaling. 
As a nonreceptor tyrosine kinase, Btk is likely to interact with several proteins within the context 
of a signal transduction pathway. To understand such interactions, we have generated glutathione 
S-transferase fusion proteins corresponding to different domains of the human Btk protein.  We 
have identified a 120-kD protein present in human B cells as being bound by the SH3 domain 
of Btk and which, after B cell receptor stimulation, is one of the major substrates of tyrosine 
phosphorylation. We have shown that this  120-kD protein is the protein product of c-cbl,  a 
protooncogene, which is known to be phosphorylated in response to T cell receptor stimulation 
and to interact with several other tyrosine kinases. Association of the SH3 domain of Btk with 
p12(Y  bt provides evidence for an analogous role for p120  'bt in B cell signaling pathways. The p120  'bt 
protein is the first identified ligand of the Btk SH3 domain. 
X 
-linked  agammaglobulinemia  (XLA)  patients  have 
mutations in the Bruton s tyrosine kinase (Btk) gene 
(1-3) and consequently suffer from a lack of mature B cells 
in thdr peripheral  blood. The identification of  Btk as a member 
of the nonreceptor tyrosine kinase family, a family of pro- 
teins already established as being involved in hematopoietic 
signal transduction, fits well with the disease phenotype of 
XLA. The Btk protein is expressed  in early and mature human 
B cell lines but is absent in terminally differentiated plasma 
cell lines, which is consistent with the requirement of a func- 
tional Btk protein for normal B cell differentiation (4-6). There 
is now evidence from a variety of sources to suggest that Btk 
is one of the many tyrosine kinases involved in B cell receptor 
(BCK) signal transduction. Stimulation of the BCR has been 
shown to lead to the tyrosine phosphorylation of Btk and 
an increase in its kinase activity  (7-10). 
The Btk protein contains Src homology (SH) regions 2 and 
3, which are noncatalytic domains present in a wide variety 
of signal transduction molecules (11). Analysis of Src-related 
tyrosine kinases suggests that these domains are involved in 
intermolecular recognition and the formation of heteromeric 
protein complexes. Signal transduction pathways are likely 
to be controlled by the formation of these protein complexes 
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(12). SH2 domains recognize tyrosine residues that have been 
phosphorylated by activated tyrosine kinases (13). Deletion 
analysis has shown that the SH3 domains of Grb2 and phos- 
pholipase C-q/are required for cellular localization (14). SH3 
domains mediate protein-protein interactions via recognition 
of specific  proline-rich peptide sequences (15, 16) and to date, 
although the sequence PXXP is always present,  most SH3 
domain ligands contain multiple prolines. Using a yeast hy- 
brid trapping method and a fusion protein system, the SH3 
domains of Fyn, Lyn, and Hck, Src-related tyrosine kinases 
known to be involved in signal transduction pathways in B 
cells, have been shown to bind to proline rich motifs present 
in the Btk protein (17). The association between Btk and 
these tyrosine kinases also implicates Btk in B cell signaling 
pathways. 
The protein targets of the SH2 and SH3 domains of Btk 
are unknown. To address this problem, we have made gluta- 
thione S-transferase  (GST) fusion protein constructs containing 
the human Btk SH2 and SH3 domains. Using these fusion 
proteins, we have identified several polypeptides  in human 
B cells that are bound by the SH3 domain of Btk in vitro. 
The protein product of c-cbl (p120  "bt) is present  in early 
B lineage and myeloid cells (18), and the SH3 domains from 
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Lck, Fgr, Nck, and PLC3,1, have already been shown to bind 
p120 'st (19, 20). The p120 'bt protein therefore appeared to be 
a good candidate for one of the polypeptides bound by the 
SH3 domain of Btk and we show here that this is indeed 
the case. The p120  'bl protein is also expressed in T cells and 
is rapidly phosphorylated after stimulation of the TCR; con- 
sequently, it is thought to be involved in this signaling pathway 
(19).  We have found that p120  'bt is rapidly phosphorylated 
after stimulation of the BCR, suggesting that it is also in- 
volved in the BCR signaling pathway. 
Materials and Methods 
GSTFusion Proteins.  The human Btk cDNA was used to am- 
plify  the  region  encoding  the  SH3  domain  from  nucleotides 
787-951, including all of the designated SH3 domain (1) with five 
additional amino acids at the COOH-terminal end, by PCR using 
the primers SH3F (5'-CTGAGGATCCGTTG~CCTTTATGA- 
TTAC) and SH3R (5'-TATCAGAATTCTGCTTCAGTGACATAG- 
TTACTAG) at  58~  with Taq polymerase (BioproTM; Bioline, 
London, UK) according to the manufacturer's instructions. The 
PCR product was cloned  into the expression  vector  pGEX-2T (Phar- 
macia Biotech, Uppsala, Sweden) and the insert was sequenced to 
ensure that no PCR mutations had been included. The fusion pro- 
tein was induced and purified as described (21) using 0.75 ml 
glutathione Sepharose (GS) beads (Pharmacia Biotech) with 800 
ml of bacterial culture. The protein concentration was estimated 
after SDS-PAGE and staining with Coomassie blue. 
Cell Lines and Cell Lysis.  A human Burkitt's lymphoma B cell 
line, Daudi, and a human T cell  line, Molt-4, were grown in RPMI 
1640, 10% FCS, 1.5 #g/ml gentamycin at 37~  to a density of 
0.5-1.0  x  l&/ml. Pelleted cells were washed in prewarmed RPMI 
1640 and either lysed  immediately  or stimulated by incubation with 
goat F(ab')2 fragment to human IgM (Organon Teknika, Durham, 
NC).  1-5  x  107 cells were lysed in 1 ml of 1% NP40, 20 mM 
Tris-HC1, pH 8.0, 130 mM NaC1, 1 mM DTT, 10 mM NaF, 1% 
aprotinin, 20 #M leupeptin, 100 #M sodium orthovanadate, I mM 
PMSF, at 4~  for 10 min. Lysates  were clarified using centrifuga- 
tion and incubated overnight at 4~  with 12 #g fusion protein 
(attached to GS beads), or with 10 #1 Agarose-conjugated anti- 
phosphotyrosine mAb (4G10; Upstate Biotechnology, Inc., Lake 
Placid, NY) per ml of cell lysate. The immobilized proteins were 
pelleted from the cell lysate, using a 15-s centrifugation at 6,000 
rpm in a microfuge, and washed five times with cold lysis buffer 
and once with PBS. The immobilized proteins were resolved in 
reducing conditions by SDS-PAGE. 
Western Analysis.  The electrophoresed  proteins were transferred 
onto Hybond C nylon membranes (Amersham  International,  Amer- 
sham, UK) using a semidry blotter. The membranes were blocked 
with 5% nonfat milk/PBS for I h at room temperature, then rinsed 
briefly twice in 0.05% Tween-20/PBS (PBS-T). The membranes 
were then incubated  in a 1:100 dilution ofanti-c-cbl antiserum (C-15; 
Santa Cruz Biotechnology Inc., Santa Cruz, CA) according to the 
manufacturers instructions. A 1/1,000 dilution of horseradish per- 
oxidase (HRP)-conjugated goat anti-rabbit IgG antiserum was used 
as a second layer. The antigen/antibody  reactions were visualized 
using the enhanced chemiluminescence detection system (Amer- 
sham) with exposure time periods ranging from 30 s to 20 rain. 
Tyrosine  phosphorylation analysis  was performed as described above 
using the mouse monoclonal 4G10 antiserum, with the incuba- 
tion in 0.5% nonfat milk/PBS-T and using HRP-conjugated rabbit 
anti-mouse  IgG2b antiserum as a second layer. 
Metabolic Labeling.  The cells  were washed twice in methionine- 
and cysteine-free  RPMI 1640 medium, suspended at 107 cells per 
ml in this media. [3SS]methionine/cysteine  (1 mCi/5  x  10  s cells, 
Tram-label; ICN, UK) was added and the cells incubated at 37~ 
for 4 h. The cells were washed twice with RPMI 1640 and then 
lysed as described above. The metabolically radiolabeled proteins 
were separated  in reducing  conditions  by SDS-PAGE and were visual- 
ized by autoradiography. 
Results and Discussion 
To identify proteins that are associated with the Btk gene 
product, we produced the human Btk SH3 domain as a GST 
fusion protein (SH3-GST) and used it to immobilize poly- 
peptide ligands from human B cell lysates. Metabolically ra- 
diolabeled Daudi cells were solubilized in lysis buffer and the 
clarified supernatants were incubated with SH3-GST immobi- 
lized to glutathione-Sepharose. The samples were washed, 
and the bound proteins were separated  by SDS-PAGE and 
then autoradiographed. A large number of polypeptides were 
bound by SH3-GST but not by GST alone,  notably those 
with apparent molecular masses of"o50, 63, 65, and 120 kD 
(Fig.  1 a). The extent of tyrosine phosphorylation of these 
polypeptides was then determined by stimulating Daudi cells 
through the BCR for a range of time periods before cell lysis 
and incubation with SH3-GST. The immobilized samples were 
immunoblotted with an antiphosphotyrosine mAb. Stimu- 
lation through the BCR led to tyrosine phosphorylation of 
at least  two of the Btk SH3 ligands that were not phos- 
phorylated in unstimulated cells (Fig.  1 b).  In particular, a 
120-kD polypeptide showed a very high level of tyrosine phos- 
phorylation after stimulation of Daudi cells (Fig.  1 b). 
The product of the c-cbl protooncogene is expressed in early 
B lineage, B and T cell lines, and myeloid cells (18) and, since 
the SH3 domains from several proteins have already been 
shown to bind p120  'st (19, 20),  this protein appeared  to be 
a good candidate for the 120-kD polypeptide bound by the 
SH3 domain of Btk. This was confirmed by incubating ly- 
sates of metabolically radiolabeled B and T  cell lines with 
SH3-GST and, after autoradiography, immunoblotting the 
immobilized proteins with anti-c-cbl antibody. In both cell 
types, p120  'bl was clearly seen to be one of the major pro- 
teins bound by the SH3-GST (Fig. 2). Other candidates for 
the phosphorylated 120-kD polypeptide included PLC3,1, as 
well as GAP and PI-3 kinase p110. Immunoblotting with 
the appropriate antsera showed that none of these proteins 
were bound by SH3-GST (results  not shown). 
The binding of p120  "bl to SH3 domains of other proteins 
has been shown to be via the COOH-terminal region of the 
protein, which includes a large proline-rich region (20). SH3 
domains have been shown to bind the PXXP motif (22), and 
p120  'bl contains 17 of these motifs. Further characterization 
of SH3 ligand binding has shown that additional prolines 
are important in stabilizing the left-handed type II polypro- 
line helix conformation bound by the SH3 domain (16, 22, 
23),  and almost all of the PXXP motifs within p120  'bt can 
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teins  in  vitro.  (a)  Daudi  cell  lysates radiolabeled  with 
[35S]methionine/cysteine,  were incubated with SH3-GST or 
GST  (see Materials  and Methods).  Bound proteins  were 
resolved  by SDS-PAGE  and visualized by autoradiography. (b) 
Daudi cells were stimulated  through the BCR for a range 
of time periods before lysis and incubation with SH3-GST 
and GST proteins. Bound proteins were visualized by immu- 
noblotting with antiphosphotyrosine  mAb. The molecular 
mass markers used are shown in kilodaltons. 
be extended to motifs consisting of three or more proline 
residues. The proline-rich region of p120  'hI therefore provides 
a large  number of potential binding sites for the SH3 do- 
mains of Btk and other proteins. The SH2 domains of Fyn, 
Lck, Blk, and other proteins have also been found to bind 
to p120~bl; however, these associations  depend on the phos- 
phorylation of the p120  ~bl protein (19). We found no evi- 
dence for any association  between the SH2 domain of Btk 
and the p120  'bl protein (results  not shown). 
The p120  "~1 expressed in T cells is rapidly phosphorylated 
after stimulation of the TCR and, consequently, it is thought 
to be involved in this  signaling pathway (19). To address 
the possibility that p120  TM performs a similar role in BCR 
signaling, BCR-stimulated Daudi cells were lysed and tyro- 
sine-phosphorylated proteins were immunoprecipitated  with 
Agarose-conjugated  antiphosphotyrosine  mAb and immuno- 
blotted with anti-c-cbl Ab (Fig. 3). The p120  'bl was immu- 
noprecipitated with antiphosphotyrosine mAb within 10 s 
of BCP, stimulation, and this high level of phosphorylation 
was maintained for 2 min. The extent of phosphorylation 
of this 120-kD  polypeptide was markedly reduced after 30 
rain (Fig. 3). The phosphorylation of p120  ~b/was also shown 
by immunoprecipitating  p120  'hI from whole-cell lysate with 
anti-c-cbl Ab followed by immunoblotting with antiphos- 
photyrosine mAb (data not shown). We have obtained evi- 
dence that p120  TM is one of the major substrates for tyrosine 
phosphorylation detected after BCR stimulation. Whole-cell 
lysates depleted of Btk SH3 domain ligands by SH3-GST 
precipitation were immunoblotted with anti-c-cbl antibody 
and  antiphosphotyrosine mAb.  Depletion of p120  '~l from 
Figure 2.  The SH3 domain of  Btk 
binds p120  "bz in vitro.  Daudi cell ly- 
sates, B cells (B) and Molt-4 cell ly- 
sates, T  cells (T) radiolabeled with 
[3SS]methionine/cysteine  were incu- 
bated with SH3-GST. (a) Bound pro- 
teins were resolved  by SDS-PAGE  and 
visualized by autoradiography.  The 
p120  'hI protein is indicated by an ar- 
row. (b) The proteins bound by the 
immobilized fusion protein were sub- 
sequently analyzed by immunoblot- 
ring with anti-c-cbl  antibody.  This 
antibody recognizes the p120  '~l pro- 
tein and a 60-kD protein. The molec- 
ular mass markers used are shown in 
kilodaltons. 
Figure 3.  p120  'bl is rapidly phos- 
phorylated  on tyrosine  after  BCP, 
stimulation. Daudi cells stimulated 
through the BCR for a range of time 
periods were lysed  and incubated with 
Agarose-conjugated  antiphosphotyro- 
sine mAb. The immunoprecipitated 
proteins were analyzed by immuno- 
blotting  with the anti-c-cbl antibody. 
The p120  ~bt protein is indicated by an 
arrow. The molecular mass markers 
used are shown in kilodaltons. 
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p120,bt is depleted  by binding to 
the SH3 domain  of  Btk after  BCR 
stimulation.  BCR-stimulated  and 
unstimulated Daudi cells were 
lysed, incubated  with either  SH3- 
GST or GST, and the subsequent 
depleted  lysates  were analyzed  by 
immunoblotting  with anti-c-cbl 
antibody  (a) and antiphosphotyro- 
sine mAb (b). Track  T is total  cell 
lysate; S is cell lysate  depleted  of 
proteins that bind to the Btk SH3 
domain; G is cell lysate  depleted 
of proteins binding to the GST 
protein. In b, the p120  m protein 
is indicated by an arrow. 
whole-cell lysates by the Btk SH3 domain was seen clearly 
in both unstimulated and stimulated cells, when compared 
to lysates after incubation with the GST protein (Fig. 4 a). 
The depletion by the SH3-GST of one of the major substrates 
for tyrosine phosphorylation was also  observed (Fig.  4  b); 
this substrate migrates to the same position as p120  cbl (Fig. 4, 
a  and b). 
Thus, p120  TM is rapidly phosphorylated after stimulation 
of the BCR in a manner analogous to that  observed  for 
pl2(F  bt in T  cells after stimulation through the TCR (19), 
suggesting that p120  "b/plays a role in BCR signaling. This 
provides yet another example of the similarities between TCR 
and BCR signaling pathways (24, 25). Previous observations 
have suggested that regulation of p120  'b/phosphorylation is 
necessary to ensure controlled cell growth (26).  Mutations 
within p120  'bt were found to induce tyrosine phosphoryla- 
tion of p120  TM and also to promote transformation of NIH 
3T3 fibroblasts and tumor formation in mice (26). The phos- 
phorylation of p120  TM after BCR and TCR activation may 
link these receptors to signaling pathways, which results in 
the controlled cell  growth of B and T  cells. 
The amount of p120  TM protein bound in vitro by the Btk 
SH3 domain was repeatedly found to decrease after BCR stim- 
ulation (Fig.  5 a). To ensure that the amount of p120  TM pro- 
Figure 5.  The  amount  of 
p120  ~bl protein bound in vitro by 
the Btk SH3 domain  decreases  af- 
ter BCR stimulation.  Daudi  cells 
were stimulated  through  the BCR 
for a range  of  time  periods, lysed, 
and incubated with GST fusion 
proteins. The proteins bound by 
the immobilized fusion protein 
were analyzed  by immunoblotting  with the anti-c-cbl antibody  (a) and 
the antiphosphotyrosine  mAb (b). To confirm that equivalent  amounts 
of SH3-GST were used in each sample the lower part of the SDS-PAGE 
gel was stained with Coomassie blue (results not shown). 
tein present in the cell lysate did not decrease after BCR stim- 
ulation, we immunoblotted the whole cell lysates,  before 
incubation with the fusion protein, with anti-c-cbl antibody 
(results not shown) and found no detectable difference in the 
available p120  'b/protein at the various time points after BCK 
stimulation. The decrease  in p121Y  bl binding to SH3-GST 
after BCK stimulation may result from a change in the struc- 
ture of the protein or from a change in the proteins associated 
with p120  'hI in vivo.  Alternatively, the phosphorylation of 
p120  cbl  observed  after  BCK  stimulation  (Fig.  5  b)  may 
directly affect the ability of the SH3 domain to bind. The 
NHz-terminal Grb2 SH3 domain showed a similar decrease 
in its binding of p120  TM after activation of T  cells (19). We 
cannot discount the possibility that other proteins present 
in the cell lysate are mediating the interaction between GST- 
SH3 and p120  TM. 
The protooncogene c-cbl  is expressed  in a large number 
of hematopoietic lineages;  however,  in vivo the oncogenic 
form, v-cbl,  is mainly transforming in early B cell lineages 
and myeloid cells (27).  The expression  of Btk is limited to 
B cell and myeloid cell lineages and the presence of a func- 
tional Btk protein in early B cell lineages  is known to be 
essential for the continued differentiation of these cells. The 
association between p120  ~bt and the Btk SH3 domain in vitro 
may have implications for the signaling pathways in mature 
B cells and also perhaps  those in early B cell lineages  and 
myeloid lineages. 
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